Interstitial Lung Disease Trial, Recruiting NCT07451977 Sponsor: Istituti Clinici Scientifici Maugeri SpA Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT07451977
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with a chronic (long-term) breathing condition and have been admitted to hospital for a lung rehabilitation program
  • People who, at the time of leaving hospital, have one of the following conditions: chronic obstructive pulmonary disease (COPD) where oxygen levels drop during physical activity; COPD with long-term breathing failure that requires ongoing oxygen therapy; or a scarring/thickening lung disease (interstitial lung disease) with long-term breathing failure that requires ongoing oxygen therapy
  • People whose condition has been medically stable for at least one month
  • People whose medications were reviewed and optimised during their hospital stay
  • People who are able to complete a standard walking test (where distance walked over 6 minutes is measured)
  • People who have given written agreement to take part in the trial

Who may not be able to join:

  • People with lung diseases other than COPD or interstitial lung disease
  • People who need more than 4 litres per minute of oxygen while at rest
  • People who have a bone, joint, nerve, or cognitive (thinking/memory) condition that may affect their ability to walk
  • People who have had a heart or stroke-related event in the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mara Paneroni, PhD, MSc, ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Lumezzane

Phone: +39 030 8253

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituti Clinici Scientifici Maugeri SpA
Registry
ClinicalTrials.gov
Start date
2 April 2026
Est. completion
31 January 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in 6-Minute Walk Distance With Supplemental Oxygen

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov